✦ LIBER ✦

Predictive Factors for Adverse Outcomes After Use of Donor Cell Infusion (DCI) in Patients with Relapsed Hematological Malignancies Treated with Allogeneic Hematopoietic Cell Transplantation (alloHCT)

✍ Scribed by N. Bejanyan; B. Bolwell; L. Rybicki; D. Abounader; H. Duong; R. Dean; R. Sobecks; S. Andresen; B. Pohlman; E. Copelan; M. Kalaycio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Comparison of Long-Term Outcomes of Do

✍ Shanavas, Mohamed; Messner, Hans A.; Kamel-Reid, Suzanne; Atenafu, Eshetu G.; Gu 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 377 KB

Prophylactic growth factor-primed donor

✍ Sang-Kyun Sohn; Jin-Tae Jung; Dong-Hwan Kim; Nan-Young Lee; Kwang-Woon Seo; Yee- 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Efficacy and Safety of Immunomodulation

✍ Horn, Biljana; Petrovic, Aleksandra; Dvorak, Christopher C.; Cowan, Morton J.; W 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Outcome of Second Transplants in Pediatr

✍ Khan, Sana; Olszewski, Marie; Kletzel, Morris 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Donor lymphocyte infusion followed by in

✍ Michal Leda; Dariusz Ladon; Anna Pieczonka; Dariusz Boruczkowski; Justyna Jólkow 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 136 KB